Maravai LifeSciences
MRVI
$0.05 (-0.51%)
1D
1W
3M
1Y
5Y
ALL
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. It also provides research products for labeling and detecting proteins in cells and tissue samples. Its products include CleanCap, messenger ribonucleic acid (mRNA) and oligonucleotide. The Biologics Safety Testing focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing spectrum. The Company provides ultra-pure nucleotides to customers in the diagnostics, pharma, genomics and research markets.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Business Wire • 8 days ago • MRVI
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping TechnologyBusiness Wire • 20 days ago • MRVI
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance ProductionGlobeNewsWire • 27 days ago • MRVI
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024GlobeNewsWire • about 2 months ago • MRVI
Maravai LifeSciences Announces March 2024 Investor Conference ScheduleGlobeNewsWire • about 3 months ago • MRVI
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial ResultsCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.